A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer. Solomon, B., Callejo, A., Bar, J., Berchem, G., Bazhenova, L., Saintigny, P., Wunder, F., Raynaud, J., Girard, N., Lee, J J., & others Cancer medicine, 11(14):2790–2800, 2022.
bibtex   
@article{solomon2022win,
  title={A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer},
  author={Solomon, Benjamin and Callejo, Ana and Bar, Jair and Berchem, Guy and Bazhenova, Lyudmila and Saintigny, Pierre and Wunder, Fanny and Raynaud, Jacques and Girard, Nicolas and Lee, J Jack and others},
  journal={Cancer medicine},
  volume={11},
  number={14},
  pages={2790--2800},
  year={2022}
}

Downloads: 0